Molecular classification and biomarkers of clinical outcome in breast ductal carcinoma in situ: Analysis of TBCRC 038 and RAHBT cohorts-Reference-Cited by-同舟云学术

Molecular classification and biomarkers of clinical outcome in breast ductal carcinoma in situ: Analysis of TBCRC 038 and RAHBT cohorts

Published:2022-12 Issue:12 Volume:40 Page:1521-1536.e7
ISSN:1535-6108
Container-title:Cancer Cell
language:en
Short-container-title:Cancer Cell

Author:

Strand Siri H.^ORCID,Rivero-Gutiérrez Belén,Houlahan Kathleen E.,Seoane Jose A.,King Lorraine M.,Risom Tyler,Simpson Lunden A.,Vennam Sujay,Khan Aziz,Cisneros Luis,Hardman Timothy,Harmon Bryan,Couch Fergus,Gallagher Kristalyn,Kilgore Mark,Wei Shi,DeMichele Angela,King Tari,McAuliffe Priscilla F.,Nangia Julie,Lee Joanna,Tseng Jennifer,Storniolo Anna Maria,Thompson Alastair M.,Gupta Gaorav P.,Burns Robyn,Veis Deborah J.,DeSchryver Katherine,Zhu Chunfang,Matusiak Magdalena,Wang Jason,Zhu Shirley X.,Tappenden Jen,Ding Daisy Yi,Zhang Dadong,Luo Jingqin,Jiang Shu,Varma Sushama,Anderson Lauren,Straub Cody,Srivastava Sucheta,Curtis Christina,Tibshirani Rob,Angelo Robert Michael,Hall Allison,Owzar Kouros,Polyak Kornelia,Maley Carlo,Marks Jeffrey R.,Colditz Graham A.,Hwang E. Shelley,West Robert B.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference48 articles.

1. American Cancer Society (2019). Breast Cancer Facts & Figures 2019-2020. https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/breast-cancer-facts-and-figures/breast-cancer-facts-and-figures-2019-2020.pdf.

2. Molecular characterization of the tumor microenvironment in breast cancer;Allinen;Cancer Cell,2004

3. Immune escape in breast cancer during in situ to invasive carcinoma transition;Gil Del Alcazar;Cancer Discov.,2017

4. Single-cell genetic analysis of ductal carcinoma in situ and invasive breast cancer reveals enormous tumor heterogeneity yet conserved genomic imbalances and gain of MYC during progression;Heselmeyer-Haddad;Am. J. Pathol.,2012

5. Molecular features of subtype-specific progression from ductal carcinoma in situ to invasive breast cancer;Lesurf;Cell Rep.,2016

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analysis of ductal carcinoma in situ by self-reported race reveals molecular differences related to outcome;Breast Cancer Research;2024-09-02

2. Systematic assessment of HER2 status in ductal carcinoma in situ of the breast: a perspective on the potential clinical relevance;Breast Cancer Research;2024-08-27

3. Evolutionary Measures Show that Recurrence of DCIS is Distinct from Progression to Breast Cancer;2024-08-16

4. The SEMA3F-NRP1/NRP2 axis is a key factor in the acquisition of invasive traits in in situ breast ductal carcinoma;Breast Cancer Research;2024-08-13

5. Biomarkers in Cancer Screening;Hematology/Oncology Clinics of North America;2024-08